Key result
PAH in commercially insured patients linked to substantial workdays lost due to health services utilization.
Cohort (n=1,588)
Patients with PAH experience substantial productivity loss due to healthcare utilization, averaging 21-23 lost workdays per year and costing up to $9,599 annually.
Answers are grounded in this paper and cite their sources.
Clinicians should account for productivity impacts when treating PAH; supports incorporating indirect costs in future economic evaluations.
BACKGROUND: Despite advances in treatment, pulmonary arterial hypertension (PAH) remains a progressive condition with the onset of disease often in working-aged adults, leading to substantial economic burden and increased healthcare resource utilization despite the rarity of the disease. The aim of this study was to estimate productivity loss for patients with PAH. METHODS: This was a retrospective cohort study of the Milliman Consolidated Health Cost Guidelines Source Data and the Merative MarketScan Commercial dataset between 01/01/2018 and 09/30/2023. Adult patients diagnosed and treated for PAH between 01/01/2019 and 08/31/2023 were identified and followed through the earliest of end of enrollment, or end of data. Outcomes were described as average workdays lost to receive healthcare services per-patient per-year (PPPY) and further assessed by healthcare setting. The cost of productivity loss was calculated based on the annual median household income. RESULTS: The study included 1,588 commercially insured patients (mean age 52 years, 63% female). Between 2019-2023, the mean number of workdays lost ranged between 21 and 23 PPPY, equating to over 8% of annual workdays. The cost of loss of productivity ranged from $8,828 to $9,599 PPPY (in 2023 dollars). Across all study years, the largest proportion of workdays lost were attributed to emergency room (ER)/observation, followed by office visits, and outpatient facilities, altogether comprising two-thirds of total workdays lost. Inpatient hospitalization-related workday loss was approximately 11% of total workdays lost. Over the study period, the largest change in workdays lost was observed for ER/observation. CONCLUSION: This study demonstrates substantial workdays lost due to health services utilization among patients with PAH, further adding to the overall economic burden of PAH. Quantifying productivity loss in PAH patients provides critical insight into the broader societal costs of the disease, supporting the inclusion of indirect costs in future economic evaluations and healthcare policy decisions.
No takes yet. Share an insight, caveat, or question.
Watzker et al. (2026) conducted a cohort in Pulmonary arterial hypertension (n=1,588). Pulmonary arterial hypertension was evaluated on Average workdays lost to receive healthcare services per-patient per-year (PPPY). Commercially insured patients with pulmonary arterial hypertension lost an average of 21 to 23 workdays per year to receive healthcare services, equating to $8,828 to $9,599 in lost productivity.
Synapse has enriched 10 related papers. Consider them for comparative context: